Login
$REKR
$0.34 +$0.05 (19.18%) Close

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current assets
Cash and cash equivalents
Restricted cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $580 and $519, respectively
Inventory
Note receivable, current portion
Other current assets
Current assets of discontinued operations
Total current assets
Long-term assets
Property and equipment, net
Right-of-use operating lease assets, net
Right-of-use financing lease assets, net
Goodwill
Intangible assets, net
Note receivable, long-term
SAFE investment
Deposits
Total long-term assets
Total assets
Current liabilities
Accounts payable and accrued expenses
Notes payable, current portion
Nonrelated Party
Related Party
Total notes payable, current portion
Loan payable, current portion
Lease liability operating, short-term
Lease liability financing, short-term
Contract liabilities
Liability for ATD Holdback Shares, at fair value
Liability for ATD Holdback Shares
Other current liabilities
Current liabilities of discontinued operations
Total current liabilities
Long-term Liabilities
Loans payable, long-term
Loan payable, long-term
Lease liability operating, long-term
Lease liability financing, long-term
Contract liabilities, long-term
Deferred tax liability
Other non-current liabilities
Related Party
Total other non-current liabilities
Total long-term liabilities
Total liabilities
Stockholders' equity
Preferred stock, $0.0001 par value, 2,000,000 authorized, 505,000 shares designated as Series A and 240,861 shares designated as Series B as of June 30, 2026 and December 31, 2025. No preferred stock was issued or outstanding as of June 30, 2026 or December 31, 2025.
Common stock, $0.0001 par value; 137,952,934 and 136,791,826 shares issued as of June 30, 2026 and December 31, 2025, respectively; 137,636,495 and 136,477,697 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
Preferred stock, $0.0001 par value, 2,000,000 authorized, 505,000 shares designated as Series A and 240,861 shares designated as Series B as of September 30, 2023 and December 31, 2022, respectively. No preferred stock was issued or outstanding as of September 30, 2023 or December 31, 2022, respectively.
Total preferred stock, $0.0001 par value, 2,000,000 authorized, 505,000 shares designated as Series A and 240,861 shares designated as Series B as of September 30, 2023 and December 31, 2022, respectively. No preferred stock was issued or outstanding as of September 30, 2023 or December 31, 2022, respectively.
Treasury stock, 316,439 and 314,129 shares as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support